• Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab
  • Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab
  • Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab
  • Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab
  • Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab
  • Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

Type: Rapid Diagnosis Test
Specimen: Nasal/Nasopharyngeal
Box Specification: 20 Tests/Box
Shelf Life: 24 Months
Test Time: 15 Minutes
Instrument Classification: Class III
Samples:
US$ 1.5/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Rating: 4.6/5
Manufacturer/Factory, Trading Company
  • Overview
  • Product Description
  • Detailed Photos
  • Test Procedure
  • Company Profile
  • Certifications
Overview

Basic Info.

Model NO.
101050
Accuracy
More Than 99.0%
Format
Cassette
Quality Certification
CE
Usage
Professional Use
Certificate
CE ISO 13485
OEM
Available
Transport Package
Carton 64*36*36.5cm
Specification
180*70*18mm
Trademark
Testsealabs
Origin
China
HS Code
3822190020
Production Capacity
3000000/Day

Product Description


 

Product Description

Quality Certification CE
Certificate CE ISO 13485
Specimen Saliva
Instrument classification Class III
Usage Professional use and home use
Shelf life 24 Months
Accuracy  More than 99.0%
OEM Available



Testsealabs® Influenza A&B Rapid Test Cassette is a rapid chromatographic immunoassay for the qualitative detection of influenza A and B antigens in nasal swab specimens. lt is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.

Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

Detailed Photos

Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal SwabInfluenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal SwabInfluenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal SwabInfluenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal SwabInfluenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal SwabInfluenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal SwabInfluenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

 

Test Procedure


DIRECTIONS FOR USE
 
Allow the test, specimen, extraction buffer to equilibrate to room
temperature (15-30°C) prior to testing.
1. Remove the test from the foil pouch and use it as soon as possible.
 
2. Place the Extraction Tube in the workstation. Hold the extraction
reagent bottle upside down vertically. Squeeze the bottle and let the
solution drop into the extraction tube freely without touching the edge
of the tube. Add 10 drops of solution to the Extraction Tube.
 
3. Place the swab specimen in the Extraction Tube. Rotate the swab for
approximately 10 seconds while pressing the head against the inside of
the tube to release the antigen in the swab.
 
4. Remove the swab while squeezing the swab head against the inside of
the Extraction Tube as you remove it to expel as much liquid as possible
from the swab. Discard the swab in accordance with your biohazard
waste disposal protocol.
 
5. Cover the tube with cap, then add 3 drops of the sample into the sample
hole vertically.
 
6. Read the result after 15 minutes. If left unread for 20 minutes or more
the results are invalid and a repeat test is recommended.



INTERPRETATION OF RESULTS
 
POSITIVE Influenza A:* Two distinct colored lines appear. One line
should be in the control line region (C) and another line should be in the
Influenza A region (A). A positive result in the Influenza A region
indicates that Influenza A antigen was detected in the sample.
POSITIVE Influenza B:* Two distinct colored lines appear. One line
should be in the control line region (C) and another line should be in the
Influenza B region (B). A positive result in the Influenza B region
indicates that Influenza B antigen was detected in the sample.
POSITIVE Influenza A and Influenza B: * Three distinct colored
lines appear. One line should be in the control line region (C) and the
other two lines should be in the Influenza A region (A) and Influenza B
region (B). A positive result in the Influenza A region and Influenza B
region indicates that Influenza A antigen and Influenza B antigen were
detected in the sample.
*NOTE: The intensity of the color in the test line regions (A or B) will
vary based on the amount of Flu A or B antigen present in the sample.
So any shade of color in the test regions (A or B) should be considered
positive.
NEGATIVE: One colored line appears in the control line region (C).
No apparent colored line appears in the test line regions (A or B). A
negative result indicates that Influenza A or B antigen is not found in the
sample, or is there but below the detection limit of the test. The patient's
sample should be cultured to make sure that there is no Influenza A or B
infection. If the symptoms do not agree with the results, get another
sample for viral culture.
INVALID: Control line fails to appear. Insufficient specimen volume or
incorrect procedural techniques are the most likely reasons for control
line failure. Review the procedure and repeat the test with a new test. If
the problem persists, discontinue using the test kit immediately and
contact your local distributor.

Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

 

Company Profile

Hangzhou Testsea Biotechnology Co., LTD. is a national high-tech enterprise, is located in Hangzhou. Testsea has lots of researchers and workers who graduated from Zhejiang University and overseas. Testsea is specialized in the research, development, production and sales of raw materials for medical diagnosis and food safety testing. We have applied for 28 kinds of patents which cover medical diagnosis, food safety rapid testing, food enzymatic immunoassay and new enzyme preparation. Testsea provides perfect raw material solutions for scientific research institutions, enterprises, research institutes and other institutions globally. Testsea total business area is more than 56,000 square meters, including 2,000 square meters of GMP 100,000-level purification workshop, our company is strictly following ISO13485 and ISO9001 quality management system operation with research, production, quality control, finance, domestic sales and international sales, etc. Our products are well accepted by many users domestic and abroad. In addition, we establish a good business relationship with many domestic universities and in vitro diagnostic production enterprises, even with southeast Asia, Europe, Africa, Latin America, and other countries.

Testsea has a research and development team led by doctors and masters with professional workers and a well-equipment facility. The production capacity of recombinant antigens has reached 18g/month.

Testsea pursuit of "integrity, quality, responsibility" concept and adhere to the quality, the purpose of serving the society and constantly developing new high-quality diagnostic materials efforts.


Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

Certifications

Influenza Antigen a+B Combo Rapid Test for Nasal/Nasopharyngeal Swab

 













 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2022

Suppliers with verified business licenses

Rating: 4.6/5
Manufacturer/Factory, Trading Company
Registered Capital
90000000 RMB
Plant Area
50000 square meters